A shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer

被引:1
作者
Takashima, Yusuke [1 ]
Komatsu, Shuhei [1 ]
Nishibeppu, Keiji [1 ]
Ohashi, Takuma [1 ]
Kosuga, Toshiyuki [1 ]
Konishi, Hirotaka [1 ]
Shiozaki, Atsushi [1 ]
Kubota, Takeshi [1 ]
Fujiwara, Hitoshi [1 ]
Otsuji, Eigo [1 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, 465 Kajii Cho,Kawaramachihirokoji,Kamigyo Ku, Kyoto 6028566, Japan
关键词
Distal surgical margin; Recurrence-free survival; Lymph node metastasis; Gastric cancer; SIEWERT TYPE-II; LYMPH-NODE; ADENOCARCINOMA; D2; LYMPHADENECTOMY; INVOLVEMENT; DISSECTION; RECURRENCE; SURGERY; LENGTH;
D O I
10.1186/s12885-023-11570-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Although a 3-5 cm surgical margin distance is recommended for advanced gastric cancer (GC) in Japanese guidelines, little is known about the clinical effects of the surgical margin, especially the distal resection margin (DM). This study aims to clarify the clinical significance of DM in GC.Methods A total of 415 GC patients who underwent curative distal gastrectomy between 2008 and 2018 were analyzed retrospectively.Results The DM significantly stratified recurrence-free survival (P = 0.002), and a DM < 30 mm was an independent factor of a poor prognosis (P = 0.023, hazard ratio: 1.91). Lymphatic recurrence occurred significantly more frequently in the DM < 30 mm group than in the DM >= 30 mm group (P = 0.019, 6.9% vs. 1.9%). Regarding the station No.6 lymph node metastases in advanced GC (DM < 30 mm vs. 30 mm <= DM <= 50 mm vs. DM > 50 mm), the number (P < 0.001, 1.42 +/- 1.69 vs. 1.18 +/- 1.80 vs. 0.18 +/- 0.64), the positive rate (P < 0.001, 59.0% vs. 46.7% vs. 11.3%) and therapeutic value index (43.3 vs. 14.5 vs. 8.0) were significantly higher in the DM < 30 mm group. By subdivision using the DM distance of 30 mm, more segmented prognostic stratifications were possible (P < 0.001).Conclusions A DM of less than 30 mm could be a surrogate marker of poor RFS, especially increasing nodal recurrence. More intensive treatment strategies, including lymphadenectomy and chemotherapy, are needed for patients with this condition.
引用
收藏
页数:10
相关论文
共 36 条
[1]   Gastric Cancer, Version 2.2013 Featured Updates to the NCCN Guidelines [J].
Ajani, Jaffer A. ;
Bentrem, David J. ;
Besh, Stephen ;
D'Amico, Thomas A. ;
Das, Prajnan ;
Denlinger, Crystal ;
Fakih, Marwan G. ;
Fuchs, Charles S. ;
Gerdes, Hans ;
Glasgow, Robert E. ;
Hayman, James A. ;
Hofstetter, Wayne L. ;
Ilson, David H. ;
Keswani, Rajesh N. ;
Kleinberg, Lawrence R. ;
Korn, W. Michael ;
Lockhart, A. Craig ;
Meredith, Kenneth ;
Mulcahy, Mary F. ;
Orringer, Mark B. ;
Posey, James A. ;
Sasson, Aaron R. ;
Scott, Walter J. ;
Strong, Vivian E. ;
Varghese, Thomas K., Jr. ;
Warren, Graham ;
Washington, Mary Kay ;
Willett, Christopher ;
Wright, Cameron D. ;
McMillian, Nicole R. ;
Sundar, Hema .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (05) :531-546
[2]   Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial [J].
Bang, Yung-Jue ;
Kim, Young-Woo ;
Yang, Han-Kwang ;
Chung, Hyun Cheol ;
Park, Young-Kyu ;
Lee, Kyung Hee ;
Lee, Keun-Wook ;
Kim, Yong Ho ;
Noh, Sang-Ik ;
Cho, Jae Yong ;
Mok, Young Jae ;
Kim, Yeul Hong ;
Ji, Jiafu ;
Yeh, Ta-Sen ;
Button, Peter ;
Sirzen, Florin ;
Noh, Sung Hoon .
LANCET, 2012, 379 (9813) :315-321
[3]   ADEQUACY OF MARGINS OF RESECTION IN GASTRECTOMY FOR CANCER [J].
BOZZETTI, F ;
BONFANTI, G ;
BUFALINO, R ;
MENOTTI, V ;
PERSANO, S ;
ANDREOLA, S ;
DOCI, R ;
GENNARI, L .
ANNALS OF SURGERY, 1982, 196 (06) :685-690
[4]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[5]   Recent Advances in the Diagnosis, Staging, Treatment, and Prognosis of Advanced Gastric Cancer: A Literature Review [J].
Chen, Zhi-da ;
Zhang, Peng-Fei ;
Xi, Hong-Qing ;
Wei, Bo ;
Chen, Lin ;
Tang, Yun .
FRONTIERS IN MEDICINE, 2021, 8
[6]   Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: A 15-year expereince at a single institute [J].
Cho, Byoung Chul ;
Jeung, Hei Cheul ;
Choi, Hye Jin ;
Rha, Sun Young ;
Hyung, Woo Jin ;
Cheong, Jae Ho ;
Noh, Sung Hoon ;
Chung, Hyun Cheol .
JOURNAL OF SURGICAL ONCOLOGY, 2007, 95 (06) :461-468
[7]   Global chemotherapy development for gastric cancer [J].
Harada, Kazuto ;
Kaya, Dilsa Mizrak ;
Shimodaira, Yusuke ;
Ajani, Jaffer A. .
GASTRIC CANCER, 2017, 20 :S92-S101
[8]   Surgical margins in gastric cancer T2 and T3 and its relationship with recurrence and overall survival at 5 years [J].
Isidro Gamboa-Hoil, Sergio ;
Adrian, Pliego-Ochoa ;
Rodrigo, Silva-Martinez ;
Juan Carlos, Silva-Godinez ;
Felix, Quijano-Castro .
SURGICAL ONCOLOGY-OXFORD, 2020, 34 :13-16
[9]   Adenocarcinoma of the gastric cardia: What is the optimal surgical approach? [J].
Ito, H ;
Clancy, TE ;
Osteen, RT ;
Swanson, RS ;
Bueno, R ;
Sugarbaker, DJ ;
Ashley, SW ;
Zinner, MJ ;
Whang, EE .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 199 (06) :880-886
[10]   Japanese gastric cancer treatment guidelines 2018 (5th edition) [J].
Japanese Gastric Cancer Association .
GASTRIC CANCER, 2021, 24 (01) :1-21